||**Balanced Wheel**|**Balanced Wheel**|**Balanced Wheel**|**1193464**|**1193464**|**1193464**|**CC16a**| |---|---|---|---|---|---|---|---| ||**For the period**
**from**|Period start date
**01/04/2024**|**To**||Period end date
**31/03/2025**||| ||||||||| |**Section A Receipts and payments**|||||||| |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest**
**£**
**1,265**
**-**
**1,265**
**-**
**-**
**-**
**1,265**
**1,702**
**-**
**250**
**554**
**200**
**2,706**
**-**
**-**
**-**
**2,706**
**- 1,441**
**-**
**13,836**
**12,395**|**Restricted**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**- # **
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**Endowment**
**funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**||**Total funds**
**to the nearest £**
**1,265**
**-**
**-**
**1,265**
**-**
**-**
**-**
**1,265**
**1,702**
**-**
**-**
**-**
**250**
**554**
**200**
**2,706**
**-**
**-**
**-**
**2,706**
**- 1,441**||**Last year**
**to the nearest £**| |Donation|**1,265**||||||**2,443**| |Grants|||||||**-**| ||**-**||||||**-**| |**_Sub total_**_(Gross income for_
_AR)_|**1,265**||||||**2,443**| ||||||||| |**A2 Asset and investment sales,**
**(see table).**|||||||| ||**-**||||||**-**| ||**-**||||||**-**| |**_Sub total_**|**-**||||||**-**| |**_Total receipts_**
**A3 Payments**|||||||| ||||||||**2,443**| ||||||||| |Information Techno;ogy|**1,702**||||||| |Zoom|**-**||||||**-**| |Bank Charges|||||||**-**| |Professional Fees|||||||**200**| |Welfare|**250**||||||| |Website|**554**||||||**400**| |Independent Examination|**200**||||||**200**| |**_Sub total_ **|**2,706**||||||**800**| ||||||||| |**A4 Asset and investment**
**purchases, (see table)**|||||||| ||**-**||||||**-**| ||**-**||||||**-**| |**_Sub total_ **|**-**||||||**-**| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||| ||||||||**800**| ||||||||| ||**- 1,441**|**-**|**-**||**- 1,441**||**1,643**| ||**-**|**-**|**-**||**-**||**-**| ||**13,836**|**-**|**-**||**13,836**||**12,193**| ||**12,395**|**-**|**-**||**12,395**||**13,836**| CCXX R1 accounts (SS) 17/01/2026 1 ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
Cash @31st March 2024
Cash @ 31 March 2025
**Details**
**Details**
**Details**
Signature
Michael Olajide|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**1,407**
**-**
**10,988**
**-**
**-**
**-**
**12,395**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
Michael Olajide|**Restricted**
**funds**
**to nearest £**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Restricted**
**funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Cost (optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Cost (optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Amount due**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||| ||||Date of
approval| ||Michael Olajide|Michael Olajide|13/01/2026| ||||| CCXX R2 accounts (SS) 17/01/2026 2